Эндоваскулярные методики профилактики и лечения сосудистого спазма вследствие разрыва церебральных аневризм: за и против
https://doi.org/10.23934/2223-9022-2021-10-4-750-759
Аннотация
В данном обзоре освещены современные подходы к эндоваскулярной терапии церебрального ангиоспазма при нетравматическом субарахноидальном кровоизлиянии вследствие разрыва церебральной аневризмы (ЦА). Освещены основные клинические рекомендательные протоколы по ведению пациентов с разрывом ЦА, представлены клинические исследования, посвященные применению баллонной ангиопластики, интраартериальному введению различных вазодилататоров, описаны преимущества и осложнения использования различных методик.
Об авторах
А. В. Природов
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»;
ФГБОУ ВО «Московский государственный медико-стоматологический университет им. А.И. Евдокимова» МЗ РФ
Россия
Россия
доктор медицинских наук, заведующий нейрохирургическим отделением, 129090, Москва, Б. Сухаревская площадь, д. 3;
профессор кафедры нейрохирургии и нейрореанимации, 127473, Москва, ул. Делегатская, д. 20, стр. 1
Е. Ю. Бахарев
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия
Россия
кандидат медицинских наук, врач нейрохирург нейрохирургического отделения,
129090, Москва, Б. Сухаревская площадь, д. 3
А. А. Калинкин
ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА России»
Россия
Россия
кандидат медицинских наук, врач нейрохирург нейрохирургического отделения,
115682, Москва, Ореховый бульвар, д. 28
Список литературы
1. Zubkov YN, Nikiforov BM, Shustin VA. Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH. Acta neurochirurgica. 1984;70(1–2):65–79. PMID: 6234754 https://doi.org/10.1007/BF01406044
2. Jun P, Ko NU, English JD, Dowd CF, Halbach VV, Higashida RT, et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Am J Neuroradiol. 2010;31(10):1911–1916. PMID: 20616179 https://doi.org/10.3174/ajnr.A2183
3. Rahme R, Jimenez L, Pyne-Geithman GJ, Serrone J, Ringer AJ, Zuccarello M, et al. Endovascular management of posthemorrhagic cerebral vasospasm: Indications, technical nuances, and results. Acta Neurochir Suppl. 2013;115:107–112. PMID: 22890655 https://doi.org/10.1007/978-3-7091-1192-5_23
4. Zwienenberg-Lee M, Hartman J, Rudisill, Madden LK, Smith K, Eskridge J, et al. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage results of a phase II multicenter, randomized, clinical trial. Stroke. 2008;39(6):1759–1765. PMID: 18420953 https://doi.org/10.1161/STROKEAHA.107.502666
5. Newell DW, Elliott JP, Eskridge JM, Winn HR. Endovascular therapy for aneurysmal vasospasm. Crit Care Clin. 1999;15(4):685–699. PMID: 10569116 https://doi.org/10.1016/s0749-0704(05)70082-8
6. Patel AS, Griessenauer CJ, Gupta R, Adeeb N, Foreman PM, Shallwani H, et al. Safety and efficacy of noncompliant balloon angioplasty for the treatment of subarachnoid hemorrhage–induced vasospasm: a multicenter study. World Nurosurg. 2017;98:189–197. PMID: 27777162 https://doi.org/10.1016/j.wneu.2016.10.064
7. Schacht H, Küchler J, Boppel T, Leppert J, Ditz C, Schramm P, et al. Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience. Clini Neurol Neurosurg. 2020;188:105590. PMID: 31759310 https://doi.org/10.1016/j.clineuro.2019.105590
8. Li K, Barras CD, Chandra RV, Kok HK, Maingard JT, Carter NS, et al. A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. World Neurosurg. 2019;126:513–527. PMID: 30898740 https://doi.org/10.1016/j.wneu.2019.03.083
9. Cho WS, Kim JE, Park SQ, Ko JK, Kim DW, Park JC, et al. Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage. J Korean Neurosurg Soc. 2018;61(2):127–166. PMID: 29526058 https://doi.org/10.3340/jkns.2017.0404.005
10. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–1737. PMID: 22556195 https://doi.org/10.1161/STR.0b013e3182587839
11. Committee for Guidelines for Management of Aneurysmal Subarachnoid Hemorrhage. Evidence-based guidelines for the management of aneurysmal subarachnoid hemorrhage. English Edition. Neurol Med Chir (Tokyo). 2012;43(6):355–429. PMID: 22912991 https://doi.org/10.2176/nmc.52.355
12. Eskridge JM, McAuliffe W, Song JK, Deliganis AV, Newell DW, Lewis DH, et al. Balloon angioplasty for the treatment of vasospasm: results of first 50 cases. Neurosurg. 1998;42(3):510–517. PMID: 9526985 https://doi.org/10.1097/00006123-199803000-00016
13. Grande A, Nichols C, Khan U, Pyne-Geithman G, Abruzzo T, Ringer A, et al. Treatment of post-hemorrhagic cerebral vasospasm: role of endovascular therapy. Acta Neurochir Suppl. 2011;110(Pt2):127–132. PMID: 21125458 https://doi.org/10.1007/978-3-7091-0356-2_23
14. Andaluz N, Tomsick TA, Tew JrJM, van Loveren HR, Yeh H-Sh, Zuccarello M. Indications for endovascular therapy for refractory vasospasm after aneurysmal subarachnoid hemorrhage: experience at the University of Cincinnati. Surgical Neurol. 2002;58(2):131–138. PMID: 12453652 https://doi.org/10.1016/s0090-3019(02)00789-9
15. Калинкин А.А., Петриков С.С. Химиоангиопластика в лечении сосудистого спазма у пациентов с разрывами аневризм артерий головного мозга. Анналы клинической и экспериментальной неврологии. 2017;11(3):60–67. https://doi.org/10.18454/ACEN.2017.3.9
16. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intraarterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Surg Neurol. 1999;51(1):66–74. PMID: 9952126 https://doi.org/10.1016/s0090-3019(97)00370-4
17. Tsurushima H, Kamezaki T, Nagatomo Y, Hyodo A, Nose T. Complications Associated with Intraarterial Administration of Papaverine for Vasospasm Following Subarachnoid Hemorrhage. Neurol Med Chir (Tokyo). 2000;40(2):112–115. PMID: 10786100 https://doi.org/10.2176/nmc.40.112
18. McAuliffe W, Townsend M, Eskridge JM, Newell DW, Grady MS, Winn HR. Intracranial pressure changes caused during papaverine infusion for treatment of vasospasm. J Neurosurg. 1995;83(3):430–434. PMID: 7666218 https://doi.org/10.3171/jns.1995.83.3.0430
19. Carhuapoma JR, Qureshi AI, Tamargo RJ, Mathis JM, Hanley DF. Intraarterial papaverine-induced seizures: case report and literature review. Surg Neurol. 2001;56(3):159–163. PMID: 11597640 https://doi.org/10.1016/s0090-3019(01)00450-5
20. Albanese E, Russo A, Quiroga M, Willis JrRN, Mericle RA, Ulm AJ. Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. J Neurosurg. 2010;113(4):913–922. PMID: 19877802 https://doi.org/10.3171/2009.9.JNS0997
21. Микеладзе К.Г., Окишев Д.Н., Белоусова О.Б., Коновалов Ан.Н., Пилипенко Ю.В., Хейреддин А.С., и др. Интраартериальное введение верапамила для профилактики и лечения церебрального ангиоспазма после САК вследствие разрыва аневризм сосудов головного мозга. Вопросы нейрохирургии имени Н.Н. Бурденко. 2018;(4):23–31.
22. Ryu CW, Koh JS, Yu SY, Kim EJ. Vasogenic edema of the Basal Ganglia after intra-arterial administration of nimodipine for treatment of vasospasm. J Korean Neurosurg Soc. 2011;49(2):112–115. PMID: 21519500 https://doi.org/10.3340/jkns.2011.49.2.112
23. Adami D, Berkefeld J, Platz J, Konczalla J, Pfeilschifter W, Weidauer S, et al. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? J Neuroradiology. 2019;46(1):15–24. https://doi.org/10.1016/j.neurad.2018.04.001
24. Kieninger M, Flessa J, Lindenberg N, Bele S, Redel A, Schneiker A, et al. Side effects of long-term continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after subarachnoid hemorrhage. Neurocrit care. 2018;28(1):65–76. PMID: 28685393 https://doi.org/10.1007/s12028-017-0428-1
25. Linfante I, Delgado-Mederos R, Andreone V, Gounis M, Hendriks L, Wakhloo AK. Angiographic and hemodynamic effects of high concentration of intra-arterial nicardipine in cerebral vasospasm. Neurosurgery. 2008;63(6):1080–1086. PMID: 19057319 https://doi.org/10.1227/01.NEU.0000327698.66596.35
26. Schmidt U, Bittner E, Pivi S, Marota JA. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone. Anesth Analg. 2010;110(3):895–902. PMID: 20185665 https://doi.org/10.1213/ANE.0b013e3181cc9ed8
27. Rosenberg N, Lazzaro MA, Lopes DK, Prabhakaran S. High-dose intra-arterial nicardipine results in hypotension following vasospasm treatment in subarachnoid hemorrhage. Neurocrit Care. 2011;15(3):400– 404. PMID: 21468780 https://doi.org/10.1007/s12028-011-9537-4
28. Enomoto Y, Yoshimura S, Yamada K, Iwama T. Convulsion during intraarterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 2010;50(1):7–11. PMID: 20098018 https://doi.org/10.2176/nmc.50.7
29. Ishihara M, Yamanaka K, Nakajima S, Yamasaki M. Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: a serious adverse event. Neuroradiology. 2012;54(1):73–75. PMID: 21431852 https://doi.org/10.1007/s00234-011-0856-0
30. Fraticelli AT, Cholley BP, Losser MR, Saint Maurice J-P, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2008; 39(3):893–898. PMID: 18239182 https://doi.org/10.1161/STROKEAHA.107.492447
31. Duman E, Karakoç F, Pinar HU, Dogan R, Fırat A, Yıldırım E. Higher dose intra-arterial milrinone and intra-arterial combined milrinonenimodipine infusion as a rescue therapy for refractory cerebral vasospasm. Interv Neuroradi. 2017;23(6):636–643. PMID: 28956512 https://doi.org/10.1177/1591019917732288
32. Suzuki S, Ito O, Sayama T, Goto K. Intra-arterial colforsin daropate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neuroradiology. 2010;52(9):837–845. PMID: 19953235 https://doi.org/10.1007/s00234-009-0631-7
33. Kassel NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77(6):848–852. PMID: 1432125 https://doi.org/10.3171/jns.1992.77.6.0848
34. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77(6):842–847. PMID: 1432124 https://doi.org/10.3171/jns.1992.77.6.0842
35. Clouston JE, Numaguchi Y, Zoarski GH, Aldrich EF, Simard JM, Zitnay KM. Intraarterial papaverine infusion for cerebral vasospasm after subarachnoid hemorrhage. AJNR Am J Neuroradiol. 1995;16(1):27– 38. PMID: 7900600
36. Sawada M, Hashimoto N, Tsukahara T, Nishi S, Kaku Y, Yoshimura S. Effectiveness of intra-arterially infused papaverine solutions of various concentrations for the treatment of cerebral vasospasm. Acta Neurochir (Wien). 1997;139(8):706–711. PMID: 9309284 https://doi.org/10.1007/BF01420042
37. Polin RS, Hansen CA, German P, Chadduck JB, Kassell NF. Intraarterially administered papaverine for the treatment of symptomatic cerebral vasospasm. Neurosurgery. 1998;42(6):1256–1267. PMID: 9632183 https://doi.org/10.1097/00006123-199806000-00031
38. Smith WS, Dowd CF, Johnston SC, Ko NU, DeArmond SJ, Dillon WP, et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke. 2004;35(11):2518–2522. PMID: 15472097 https://doi.org/10.1161/01.STR.0000144682.00822.83
39. Hosmann A, Wang WT, Dodier P, Bavinzski G, Engel A, Herta J, et al. The Impact of Intra-Arterial Papaverine-Hydrochloride on Cerebral Metabolism and Oxygenation for Treatment of Delayed-Onset PostSubarachnoid Hemorrhage Vasospasm. Neurosurgery. 2019;87(4):712– 719. PMID: 31792510 https://doi.org/10.1093/neuros/nyz500
40. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results. AJNR Am J Neuroradiol. 2004;25(6):1067–1076. PMID: 15205150
41. Hui C, Lau KP. Efficacy of intra-arterial nimodipine in the treatment of cerebral vasospasm complicating subarachnoid haemorrhage. Clinical radiology. 2005;60(9):1030–1036. PMID: 16124986 https://doi.org/10.1016/j.crad.2005.04.004
42. Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ. Intraarterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion. AJNR Am J Neuroradiol. 2008;29(6):1053–1060. PMID: 18372422 https://doi.org/10.3174/ajnr.A1005
43. Kerz T, Boor S, Beyer C, Welschehold S, Schuessler A, Oertel J. Effect of intraarterial papaverine or nimodipine on vessel diameter in patients with cerebral vasospasm after subarachnoid hemorrhage. Br J of Neurosurgery. 2012;26(4):517–524. PMID: 22303863 https://doi.org/10.3109/02688697.2011.650737
44. Cho WS, Kang HS, Kim JE, Kwon O-K, Oh CW, Son YJ, et al. Intra-arterial nimodipine infusion for cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. Interv Neuroradiol. 2011;17(2):169–178. PMID: 21696654 https://doi.org/10.1177/159101991101700205
45. Kim SS, Dong-Hyuk P, Dong-Jun L, Kang SH, Cho TH, Chung YG. Angiographic Features and Clinical Outcomes of Intra-Arterial Nimodipine Injection in Patients with Subarachnoid HemorrhageInduced Vasospasm. J Korean Neurosurg Soc. 2012;52(3):172–178. PMID: 23115657 https://doi.org/10.3340/jkns.2012.52.3.172
46. Ott S, Jedlicka S, Wolf S, Peter M, Pudenz C, Merker P, et al. Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage. Biomed Res Int. 2014;2014:970741. PMID: 24527461 https://doi.org/10.1155/2014/970741
47. Narayan V, Pendharkar H, Devi BI, Bhat DI, Shukla DP. Aggressive management of vasospasm with direct intra-arterial nimodipine therapy. Neurol India. 2018;66(2):416–422. PMID: 29547164 https://doi.org/10.4103/0028-3886.227295
48. Badjatia N, Topcuoglu MA, Pryor JC, Rabinov JD, Ogilvy CS, Carter BS, et al. Preliminary experience with intra-arterial nicardipine as a treatment for cerebral vasospasm. ANJR Am J Neuroradiol. 2004;25(5):819–826. PMID: 15140728
49. Tejada JG, Taylor RA, Ugurel MS, Hayakawa M, Lee SK, Chaloupka JC. Safety and feasibility of intra-arterial nicardipine for the treatment of subarachnoid hemorrhage-related vasospasm: initial clinical experience with high-dose infusions. AJNR Am J Neuroradiol. 2007;28(5):844–848. PMID: 17494654
50. Shah QA, Memon MZ, Suri MF, Rodriguez GJ, Kozak OS, Taylor RA, et al. Super-selective intra-arterial magnesium sulfate in combination with nicardipine for the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage. Neurocrit Care. 2009;11(2):190–198. PMID: 19370322 https://doi.org/10.1007/s12028-009-9209-9
51. Pandey P, Steinberg GK, Dodd R, Do HM, Marks MP. A simplified method for administration of intra-arterial nicardipine for vasospasm with cervical catheter infusion. Neurosurgery. 2012;71(1 Suppl Operative):77– 85. PMID: 22105209 https://doi.org/10.1227/NEU.0b013e3182426257
52. Park ES, Kim DW, Kang SD. Endovascular treatment of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage: a three-year experience. J Cerebrovasc Endovascular Neurosurgery. 2017;19(3):155– 161. PMID: 29159148 https://doi.org/10.7461/jcen.2017.19.3.155
53. Feng L, Fitzsimmons BF, Young WL, Berman MF, Lin E, Aagaard BD, et al. Intra-administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience. AJNR Am J Neuroradiol. 2002;23(8):1284–1290. PMID: 12223366
54. Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after subarachnoid hemorrhage aneurysm. J Neurosurg. 2008;108(3):458–463. PMID: 18312091 https://doi.org/10.3171/JNS/2008/108/3/0458
55. Stuart RM, Helbok R, Kurtz P, Schmidt M, Fernandez L, Lee K, et al. Highdose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery. 2011;68(2):337–345. PMID: 21135735 https://doi.org/10.1227/NEU.0b013e318201be47
56. Tachibana E, Harada T, Shibuya M, Saito K, Takayasu M, Suzuki Y, et al. Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage. Acta Neurochir (Wien). 1999;141(1):13–19. PMID: 10071681 https://doi.org/10.1007/s007010050260
57. Tanaka K, Minami H, Kota M, Kuwamura K, Kohmura E. Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride. Neurosurgery. 2005;56(2):214–223. PMID: 15670369 https://doi.org/10.1227/01.neu.0000147975.24556.bc
58. Iwabuchi S, Yokouchi T, Hayashi M, Sato K, Saito N, Hirata Y, et.al. Intra-arterial Administration of Fasudil Hydrochloride for Vasospasm Following Subarachnoid Haemorrhage: Experience of 90 Cases. Acta Neurochir. 2011;110(2):179–181. PMID: 21125468 https://doi.org/10.1007/978-3-7091-0356-2_33
59. Nakamura T, Matsui T, Hosono A, Okano A, Fujisawa N, Tsuchiya T, et al. Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH. Acta Neurochir Suppl. 2013;115:81–85. PMID: 22890650 https://doi.org/10.1007/978-3-7091-1192-5_18
60. Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery. 2001;48(4):723–730. PMID: 11322432 https://doi.org/10.1097/00006123-200104000-00004
61. Shankar JJ, dos Santos MP, Deus-Silva L, Lum C. Angiographic evaluation of the effect of intra-arterial milrinone therapy in patients with vasospasm from aneurysmal subarachnoid hemorrhage. Neuroradiology. 2011;53(2):123–128. PMID: 20549498 https://doi.org/10.1007/s00234-010-0720-7
62. Sherif C, Wambacher B, Loyoddin M, Karaic R, Krafft P, Valentin A, et al. Repeated combined endovascular therapy with milrinone and nimodipine for the treatment of severe vasospasm: preliminary results. Acta Neurochir Suppl. 2015;120:203–207. PMID: 25366625 https://doi.org/10.1007/978-3-319-04981-6_35
63. Suzuki S, Ito O, Sayama T, Yamaguchi S, Goto K, Sasaki T. Intraarterial injection of colforsin daropate hydrochloride for the treatment of vasospasm after aneurysmal subarachnoid hemorrhage: preliminary report of two cases. Neuroradiology. 2006;48(1):50–53. PMID: 16261335 https://doi.org/10.1007/s00234-005-0014-7
64. Suzuki S, Sato M, Ota S, Fukushima T, Ota A, Ota T, et al Intraarterial colforsin may improve the outcome of patients with aneurysmal subarachnoid hemorrhage: a retrospective study. World Neurosurg. 2012;78(3–4):295–259. PMID: 22120553 https://doi.org/10.1016/j.wneu.2011.10.046
Рецензия
Для цитирования:
Природов А.В., Бахарев Е.Ю., Калинкин А.А. Эндоваскулярные методики профилактики и лечения сосудистого спазма вследствие разрыва церебральных аневризм: за и против. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2021;10(4):750-759. https://doi.org/10.23934/2223-9022-2021-10-4-750-759
For citation:
Prirodov A.V., Bakharev E.Yu., Kalinkin A.A. Endovascular Methods of Prevention and Treatment of Vascular Spasm Due to Rupture of Cerebral Aneurysms: Pros and Cons. Russian Sklifosovsky Journal "Emergency Medical Care". 2021;10(4):750-759. https://doi.org/10.23934/2223-9022-2021-10-4-750-759
Просмотров:
77176
Послать статью по эл. почте 